Key result
Vanadate reversibly inhibited force development elicited by Ca2+ in skinned smooth muscle fibers and increased the rate of tension loss by 10-fold.
Vanadate inhibits smooth muscle contraction by acting on the actin-myosin-ADP intermediate during the cross-bridge cycle.
May inform smooth muscle pharmacology research; leaves open clinical translation to human tissues.
Vanadate (Vi, 3-300 microM) reversibly inhibited force development elicited by micromolar Ca2+ in membrane-skinned fibers of smooth muscle from taenia coli and trachea of guinea pig. When relaxed fibers were preincubated with Vi, the contraction to Ca2+ was characterized by a peak response followed by a lower steady-state phase. The peak phase depended on the rate of contraction and the [Vi]and was absent after Vi incubation during a previous contraction. These observations were consistent with Vi binding to a site that was exposed during the cross-bridge cycle but absent in the relaxed state. The actin X myosin X ADP intermediate formed at the active site during the cross-bridge cycle is suggested as the site of action of Vi. A weak antagonism between Pi and Vi was demonstrated during contractions activated by myosin thiophosphorylation. High concentrations of Pi (6-12 mM) were needed to produce a small inhibition (10%) of maximal Ca2+-activated tension. Skinned fibers relaxed slowly after Ca2+ removal, and the absence of an active state suggested that tension was maintained by noncycling cross bridges. Both Vi and Pi increased the rate of tension loss by 10-fold, but Vi was 5-10 times more potent than Pi. It is suggested that Vi and Pi both act on the active site but that Pi has a more efficacious action on slowly cycling than rapidly cycling cross bridges.
No takes yet. Share an insight, caveat, or question.
Nayler et al. (1986) studied this question. Vanadate was evaluated on Force development and tension loss. Vanadate reversibly inhibited force development elicited by Ca2+ in skinned smooth muscle fibers and increased the rate of tension loss by 10-fold.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: